Prokarium and Probiomed in UK-Mexico collaboration to scale-up manufacture of thermostable vaccines with a focus on diarrhoea

Keele, UK and Mexico City, MX, 4th January 2017 Prokarium and Probiomed today announced the start of their collaboration to scale-up the manufacture of orally administered vaccines in a formulation that would enable stability at 40°C for several weeks. The first vaccine to be manufactured will be developed to prevent so-called ‘Montezuma’s revenge’ or diarrhoea, which Read more Prokarium and Probiomed in UK-Mexico collaboration to scale-up manufacture of thermostable vaccines with a focus on diarrhoea

Prokarium to present at ‘Future Challenges of Manufacturing Biopharmaceuticals’ conference, 30th Nov. 2016, London

Prokarium's Chief Scientific Officer, Dr Rocky Cranenburgh, will discuss the innovative manufacturing technologies developed to support the Vaxonella platform at this 'Genesis Fringe' event at Read more Prokarium to present at ‘Future Challenges of Manufacturing Biopharmaceuticals’ conference, 30th Nov. 2016, London